H23 Pill - brown oval
Pill with imprint H23 is Brown, Oval and has been identified as Minocycline Hydrochloride Extended-Release 135 mg. It is supplied by Global Pharmaceuticals.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for H23
Minocycline Hydrochloride Extended-Release
- Imprint
- H23
- Strength
- 135 mg
- Color
- Brown
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Global Pharmaceuticals
- National Drug Code (NDC)
- 00115-1247 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
hypromelloses,
magnesium stearate,
titanium dioxide,
triacetin,
polydextrose,
polyethylene glycol,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "H23"
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Ximino, Minocin for Injection, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.